Pms-Methotrexate Injection 12.5 mg

PMS-Methotrexate Injection 12.5 mg is a subcutaneous solution used for various medical conditions. This medication, containing methotrexate sodium, is manufactured by Pharmascience Inc. in Canada.

PMS-Methotrexate Injection 12.5 mg is commonly used for its antimetabolite properties. It is often prescribed for conditions requiring disease-modifying drugs, including certain types of cancer and autoimmune disorders. The injection is designed for subcutaneous administration, allowing for targeted delivery. What is methotrexate used for? It is primarily utilized in treatments where cell growth needs to be controlled, such as in cancer therapy or autoimmune disease management.

Common effects of PMS-Methotrexate Injection 12.5 mg may include temporary discomfort at the injection site. Some users might experience fatigue or mild gastrointestinal disturbances. These effects vary among individuals and are not exhaustive. Always consult a healthcare provider for personalized advice.

Handle PMS-Methotrexate Injection 12.5 mg with care, ensuring proper storage and administration. It is crucial to follow the prescribed guidelines for subcutaneous injection. Avoid self-administration without professional guidance. Store the medication as directed to maintain its efficacy.

PMS-Methotrexate Injection 12.5 mg may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other immunosuppressants. Alcohol consumption should be avoided. Always inform your healthcare provider about all medications you are taking to prevent potential interactions.